Insider Transactions in Q2 2021 at Crispr Therapeutics Ag (CRSP)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2021
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
25,000
-4.18%
|
$4,125,000
$165.0 P/Share
|
|
Jun 29
2021
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Direct |
47,536
-39.89%
|
$7,082,864
$149.03 P/Share
|
|
Jun 28
2021
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
25,000
-4.01%
|
$3,900,000
$156.55 P/Share
|
|
Jun 28
2021
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
10,000
-0.87%
|
$1,530,000
$153.49 P/Share
|
|
Jun 28
2021
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Direct |
20,375
-49.72%
|
$3,117,375
$153.49 P/Share
|
|
Jun 28
2021
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Direct |
47,536
+26.88%
|
-
|
|
Jun 28
2021
|
Bradley J Ph D Bolzon Director |
SELL
Other acquisition or disposition
|
Indirect |
1,285,027
-81.0%
|
-
|
|
Jun 28
2021
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Indirect |
248,625
+31.17%
|
-
|
|
Jun 21
2021
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
25,000
-0.65%
|
$3,200,000
$128.07 P/Share
|
|
Jun 15
2021
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
30,000
-4.79%
|
$3,780,000
$126.59 P/Share
|
|
Jun 15
2021
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+12.11%
|
$360,000
$12.57 P/Share
|
|
Jun 11
2021
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Direct |
10,000
-7.51%
|
$1,270,000
$127.64 P/Share
|
|
Jun 01
2021
|
Samarth Kulkarni Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
779
-0.41%
|
$89,585
$115.8 P/Share
|